NeoGenomics, Inc. (NEO)
16.62
+0.20
(+1.22%)
USD |
NASDAQ |
Oct 20, 16:00
16.70
+0.08
(+0.48%)
Pre-Market: 08:31
NeoGenomics Research and Development Expense (TTM) : 38.17M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 38.17M |
| March 31, 2026 | 36.43M |
| December 31, 2025 | 37.08M |
| September 30, 2025 | 35.87M |
| June 30, 2025 | 34.86M |
| March 31, 2025 | 33.72M |
| December 31, 2024 | 31.16M |
| September 30, 2024 | 30.32M |
| June 30, 2024 | 27.92M |
| March 31, 2024 | 27.53M |
| December 31, 2023 | 27.31M |
| September 30, 2023 | 26.86M |
| June 30, 2023 | 28.88M |
| March 31, 2023 | 30.01M |
| December 31, 2022 | 30.33M |
| September 30, 2022 | 32.16M |
| June 30, 2022 | 32.26M |
| March 31, 2022 | 27.13M |
| December 31, 2021 | 21.87M |
| September 30, 2021 | 15.46M |
| June 30, 2021 | 10.02M |
| March 31, 2021 | 8.625M |
| December 31, 2020 | 8.229M |
| September 30, 2020 | 8.209M |
| June 30, 2020 | 8.856M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.338M |
| December 31, 2019 | 8.487M |
| September 30, 2019 | 6.933M |
| June 30, 2019 | 4.768M |
| March 31, 2019 | 3.254M |
| December 31, 2018 | 3.001M |
| September 30, 2018 | 3.031M |
| June 30, 2018 | 3.855M |
| March 31, 2018 | 3.729M |
| December 31, 2017 | 3.635M |
| September 30, 2017 | 4.009M |
| June 30, 2017 | 3.706M |
| March 31, 2017 | 4.01M |
| December 31, 2016 | 4.468M |
| September 30, 2016 | 5.338M |
| June 30, 2016 | 5.186M |
| March 31, 2016 | 4.678M |
| December 31, 2015 | 3.971M |
| September 30, 2015 | 2.49M |
| June 30, 2015 | 2.60M |
| March 31, 2015 | 2.435M |
| December 31, 2014 | 2.394M |
| September 30, 2014 | 2.668M |
| June 30, 2014 | 2.027M |
| March 31, 2014 | 2.01M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median